Cash Flow Statement

Amortization Capital Expenditures Cash from Financing Activities Cash from Investing Activities Cash from Operations Change in Account Payables Change in Cash Change in Intangibles Change in Inventory Change in Receivables Depreciation & Amortization (CF)Exchange Rate Effect Free Cash Flow Net Cash Flow Net Income Other Working Capital Changes Share-based Compensation

Daily Values

Growth Metrics

Others

Ratios

Mainz Biomed (MYNZ) Asset Writedowns and Impairment (2022 - 2023)

Historic Asset Writedowns and Impairment for Mainz Biomed (MYNZ) over the last 1 years, with Q3 2023 value amounting to $42045.0.